Contact Us
(833) 486-3753

Category: MedComms

Medical Affairs Has a Communication Problem: MAX 2026 Challenged the Field to Fix It

On March 25, 2026, I attended MAX: Medical Affairs eXcellence Forum, Canada’s first forum dedicated entirely to medical affairs in biopharma. Organized by Agilis Health and held at the Sheraton Toronto Airport, it brought together 140+ professionals spanning Medical Affairs, Pharma, Clinical Research, Regulatory, and Medical Communications for a full day of candid, high-calibre conversation. …

Misinformation, AI Hallucinations & The Communications Failures of 2025

2025 will go down as the year communication cracked under pressure. With health anxieties high and digital tools more accessible than ever, misinformation didn’t stay online; it seeped into exam rooms, treatment decisions, and patient minds. At the same time, the rapid embrace of generative AI promised to revolutionize medical education, content creation, and patient …

What Happens When Healthcare Communications Break Down?

Imagine opening an email from your regional public health authority – or perhaps you don’t have to imagine at all. Many of us with school-aged children in Ontario have received one recently, a stark reminder of how fragile our sense of safety can feel when public trust in preventive care begins to waver. “Dear Parent/Guardian, …

Beyond Deadlines: The Growing Demands on MedComms

The life science industry has never moved faster, and the pace is only accelerating. Pipelines in oncology, rare disease, and cell and gene therapy are advancing with unprecedented velocity. Regulatory timelines are tightening, and the volume of new data is overwhelming traditional workflows. For medical communications agencies, this isn’t just about “keeping up.” It’s about …

Beyond Freelance: Why Medical Communications Needs Structure, Not Just Talent

A First-Hand Lesson in the Limits of Freelance Support A little while back, an agency partner brought us into a high-pressure situation. Their client, a major pharmaceutical company, was preparing for a product launch in Canada following regulatory approval. They needed a full suite of HCP-facing materials: several slide decks, marketing collateral, and talking points. …